tiprankstipranks
Neumora Therapeutics, Inc. (NMRA)
NASDAQ:NMRA
US Market
NMRA
Neumora Therapeutics, Inc.
RESEARCH TOOLSreports

Neumora Therapeutics, Inc. (NMRA) Cash flow

406 Followers

Neumora Therapeutics, Inc. Cash Flow

NMRA's free cash flow for Q4 2025 was $-47.94M. For the 2025 fiscal year, NMRA's free cash flow was decreased by $-23.50M and operating cash flow was $-47.95M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -206.44M$ -182.94M$ -163.28M$ -114.90M$ -75.42M
Investing Cash Flow
$ 168.52M$ -70.56M$ 64.39M$ -168.01M$ -817.00K
Financing Cash Flow
$ 77.09M$ 21.60M$ 231.94M$ 115.74M$ 293.51M
End Cash Position
$ 182.53M$ 143.36M$ 375.25M$ 242.21M$ 409.37M
Free Cash Flow
$ -206.44M$ -182.94M$ -163.40M$ -115.41M$ -76.24M
Currency in USD

Neumora Therapeutics, Inc. Cash Flow